Epilepsy Medication Tied To Autism

Depcon | Valproate | The Maher Law Firm

A fetus exposed to Valproic Acid (Depacon) has a five-fold elevated risk of developing autism and three-fold elevated risk for developing autism spectrum disorder Valproic acid (VPA), is an acidic chemical compound that is used as an anticonvulsant and mood-stabilizing drug, primarily in the treatment of epilepsy, bipolar disorder, and, less commonly, major depression, migraine [...]

Abbott Labs in Settlement Talks Over Depakote Marketing

Depakote | The Maher Law Firm

Depakote and Autism The U.S. Justice Department is currently engaged in settlement negotiations with Abbott Laboratories regarding the government’s lawsuit alleging the company improperly marketed its epilepsy drug, Depakote. In the suit, whistleblowers claimed that Abbot Park, Illinois-based Abbott Labs, marketed Depakote for unapproved uses such as agitation and aggression in patients with autism, dementia [...]